ADAPT: Adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer.
Nadia Harbeck
No relevant relationships to disclose
Daniel Hofmann
No relevant relationships to disclose
Oleg Gluz
No relevant relationships to disclose
Ronald E. Kates
No relevant relationships to disclose
Sherko Kümmel
No relevant relationships to disclose
Benno Nuding
No relevant relationships to disclose
Mahdi Rezai
No relevant relationships to disclose
Manfred Kusche
No relevant relationships to disclose
Claudia Schumacher
No relevant relationships to disclose
Ulrike Nitz
No relevant relationships to disclose